tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Aditxt Amends Merger Agreement with Evofem

Story Highlights
Aditxt Amends Merger Agreement with Evofem

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Aditxt ( (ADTX) ) is now available.

Aditxt, Inc. has been actively working on a merger with Evofem Biosciences, Inc., with the latter becoming a wholly owned subsidiary. The merger agreement has undergone several amendments, with the latest being Amendment No. 6 on August 26, 2025. These amendments have included changes to investment amounts, dates, and shareholder approval definitions, reflecting ongoing negotiations and adjustments in the merger process.

More about Aditxt

Average Trading Volume: 842,954

Technical Sentiment Signal: Strong Sell

Current Market Cap: $5.28M

See more insights into ADTX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1